GDP366


CAS No. : 501698-03-9

501698-03-9
Price and Availability of CAS No. : 501698-03-9
Size Price Stock
1mg $261 In-stock
5mg $550 In-stock
10mg $850 In-stock
25mg $1750 In-stock
50mg $2750 In-stock
100mg $3950 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-U00177
M.Wt: 375.45
Formula: C20H17N5OS
Purity: >98 %
Solubility: DMSO : 62.5 mg/mL (ultrasonic)
Introduction of 501698-03-9 :

GDP366, a dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. IC50 & Target: Survivin[1]
Op18[1] In Vitro: GDP366 potently and selectively inhibits the expression of both survivin and Op18. GDP366 decreass both the mRNA and protein levels of survivin and Op18. This inhibitory effect is not dependent on the status of p53 and p21 although GDP366 potently increases p53 and p21 levels. GDP366 significantly inhibits the growth of tumor cells in vitro and in vivo (nude mouse model) without rapid induction of apoptosis. GDP366 induces polyploidy in multiple types of cancer cell lines. GDP366 increases chromosomal instability, and induces cellular senescence by inhibiting telomerase activity[1].

Your information is safe with us.